SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

Journals Menu

"SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia"
written by Fatih M. Uckun, Sanjive Qazi,
published by Journal of Cancer Therapy, Vol.5 No.1, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Candida Administration Worsens Neutrophil Extracellular Traps in Renal Ischemia Reperfusion Injury Mice: An Impact of Gut Fungi on Acute Kidney Injury
	Journal of Innate …, 2022

[2]	Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance
	Cancer Drug Resistance, 2022

[3]	Wilasinee Saisorn 1, 2, Supichcha Saithong 3, Pornpimol Phuengmaung2, 3, Kanyarat Udompornpitak 3, Thansita Bhunyakarnjanarat 3, Peerapat Visitchanakun 3
	Innate Immunity in Kidney Injury …, 2022

[4]	Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With …
	2021

[5]	Nanocarriers as Magic Bullets in the Treatment of Leukemia
	2020

[6]	Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase
	2020

[7]	Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors
	2020

[8]	Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
	2020

[9]	NCI Alliance for Nanotechnology in Cancer–Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics
	2019

[10]	National Cancer Institute Alliance for nanotechnology in cancer—Catalyzing research and translation toward novel cancer diagnostics and therapeutics
	2019

[11]	Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1‐mutant and 1p/19q‐codeleted: a multicenter study from …
	2019

[12]	Role of Syk gene promoter demethylation in the biological behavior of medulloblastoma
	2019

[13]	Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays
	Oncotarget, 2018

[14]	Spleen tyrosine kinase (SYK) protects renal tubular epithelial cell against hypoxia injury in children with acute kidney injury
	Gene, 2018

[15]	Role of Protein Kinases and Their Inhibitors in Radiation Response of Tumor Cells
	Current Pharmaceutical Design, 2017

[16]	Syk inhibitors in clinical development for hematological malignancies
	2017

[17]	An in vivo RNAi therapy screen identifies novel mediators of leukemia-microenvironment interaction
	2017

[18]	Вплив інгібітора протеїнкіназ похідного малеіміду на морфофункціональний стан мишачих лейкемічних клітин L1210
	В?сник Льв?вського ун?верситету. Сер?я б?олог?чна , 2016

[19]	Therapeutic Approaches to Drug Targets in Leukemia
	Int J Ayu Pharm Chem, 2016

[20]	Recent advances and novel treatment paradigms in acute lymphocytic leukemia
	2016

[21]	Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3
	Oncotarget, 2016

[22]	Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.
	Oncotarget, 2016

[23]	Lipid Phosphatases and Oxidative Signalling in T Lymphocytes
	2015

[24]	A Woman With CD19-Positive, B-Cell ALL
	2015

[25]	Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
	2015

[26]	Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
	Journal of cellular and molecular medicine, 2015

[27]	21: Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
	Stem Cells, 2015

[28]	Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia
	Haematologica, 2015

[29]	The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
	Leukemia, 2015

[30]	Somatic copy number losses on chromosome 9q21. 33q22. 33 encompassing the PTCH1 loci associated with cardiac fibroma
	Cancer genetics, 2015

[31]	Appendix: Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
	Signature redacted, 2015

[32]	Precursor B-cell acute lymphoblastic leukemia and the problem ofminimal residual disease
	2015

[33]	Lipid Phosphatases and Oxidative Signalling in T Lymphocyte Biology
	2015

[34]	Somatic copy number losses on chromosome 9q21.33q22.33 encompassing the PTCH1 loci associated with cardiac fibroma
	Cancer Genetics, 2015

[35]	Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
	Stem Cells, Tissue Engineering and Regenerative Medicine, 2014

[1]	Blue Light Inhibits Proliferation of Metastatic Cancer Cells by Regulating Translational Initiation: A Synergistic Property with Anticancer Drugs Photochemistry and Photobiology, 2023 DOI:10.1111/php.13789

[2]	Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors Bioorganic & Medicinal Chemistry Letters, 2023 DOI:10.1016/j.bmcl.2023.129352

[3]	Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors Bioorganic & Medicinal Chemistry Letters, 2023 DOI:10.1016/j.bmcl.2023.129352

[4]	Blue Light Inhibits Proliferation of Metastatic Cancer Cells by Regulating Translational Initiation: A Synergistic Property with Anticancer Drugs Photochemistry and Photobiology, 2023 DOI:10.1111/php.13789

[5]	*Candida* Administration Worsens Neutrophil Extracellular Traps in Renal Ischemia Reperfusion Injury Mice: An Impact of Gut Fungi on Acute Kidney Injury Journal of Innate Immunity, 2022 DOI:10.1159/000521633

[6]	Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury Frontiers in Immunology, 2021 DOI:10.3389/fimmu.2021.669162

[7]	Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase Bioorganic & Medicinal Chemistry Letters, 2020 DOI:10.1016/j.bmcl.2020.127393

[8]	Optimization of a Series of Potent, Selective and Orally Bioavailable SYK Inhibitors Bioorganic & Medicinal Chemistry Letters, 2020 DOI:10.1016/j.bmcl.2020.127433

[9]	Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors Bioorganic & Medicinal Chemistry Letters, 2020 DOI:10.1016/j.bmcl.2020.127523

[10]	Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1‐mutant and 1p/19q‐codeleted: a multicenter study from the French POLA network Brain Pathology, 2020 DOI:10.1111/bpa.12788

[11]	Nanocarriers as Magic Bullets in the Treatment of Leukemia Nanomaterials, 2020 DOI:10.3390/nano10020276

[12]	Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1 ‐mutant and 1p/19q‐codeleted: a multicenter study from the French POLA network Brain Pathology, 2019 DOI:10.1111/bpa.12788

[13]	National Cancer Institute Alliance for nanotechnology in cancer—Catalyzing research and translation toward novel cancer diagnostics and therapeutics WIREs Nanomedicine and Nanobiotechnology, 2019 DOI:10.1002/wnan.1570

[14]	Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays Oncotarget, 2018 DOI:10.18632/oncotarget.24853

[15]	WITHDRAWN: Spleen tyrosine kinase (SYK) protects renal tubular epithelial cell against hypoxia injury in children with acute kidney injury Gene, 2018 DOI:10.1016/j.gene.2018.11.013

[16]	Syk inhibitors in clinical development for hematological malignancies Journal of Hematology & Oncology, 2017 DOI:10.1186/s13045-017-0512-1

[17]	Recent advances and novel treatment paradigms in acute lymphocytic leukemia Therapeutic Advances in Hematology, 2016 DOI:10.1177/2040620716652289

[18]	Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3 Oncotarget, 2016 DOI:10.18632/oncotarget.7151

[19]	Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia Journal of Cellular and Molecular Medicine, 2015 DOI:10.1111/jcmm.12507

[20]	Somatic copy number losses on chromosome 9q21.33q22.33 encompassing the PTCH1 loci associated with cardiac fibroma Cancer Genetics, 2015 DOI:10.1016/j.cancergen.2015.09.006

[21]	The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia Leukemia, 2015 DOI:10.1038/leu.2015.113

[22]	Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia Journal of Cellular and Molecular Medicine, 2015 DOI:10.1111/jcmm.12507

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies